http://www.bioregio-stern.de/en/news-press/press-releases (20.05.2013)
Pressemitteilungen
Title |
Content | Date |
|---|---|---|
| Harnessing Synergies – Medtech and Biotech | Cooperation between the medtech and biotech sectors gives rise to synergy effects that enable patients to benefit not only from less invasive treatment but also from faster healing. | 31.03.2006 |
| High-Tech Gründerfonds invests in Subitec GmbH | Talks had lasted for just three months when this first round of financing was secured, says Dr. Peter Ripplinger, CEO of Subitec GmbH. | 06.06.2007 |
| High-tech horticulture impresses leading politicians | "Three amateur flower fans are keen to find out how this industry works," declared Minister President Oettinger at the start of the guided tour of Selecta Klemm GmbH & Co. KG. | 13.11.2007 |
| Highly innovative industries with communication needs | The new study "Harnessing and realizing synergies: Cooperations between biotechnology and medical technology companies" by BioRegio STERN Management GmbH and Capgemini Deutschland GmbH is now avail | 19.07.2006 |
| Hope for patients with vascular occlusion | Stuttgart-based biotechnology company IVB IN VITRO BIOTEC GmbH has begun producing cell-coated vascular prostheses. | 19.06.2005 |
| Hope for the blind thanks to business angels | Reutlingen-based medtech company Retina Implant AG is developing an electronic chip that is implanted in the eye under the retina and will restore partial vision to many blind people. | 18.04.2005 |
| Identifying infected cows and sheep faster | The Schmallenberg virus was first detected on a livestock farm in Germany in November 2011 and has since spread throughout the whole of Europe. | 17.07.2012 |
| Identifying infected cows and sheep faster | The world's first commercial detection method for the Schmallenberg virus is now available for all laboratories. Kornwestheim-based AnDiaTec GmbH & Co. | 12.07.2012 |
| immatics presents encouraging overall survival data from a phase 2 study in Advanced Colorectal Cancer at the ASCO Annual Meeting | Tuebingen, June 1, 2012 – immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that its | 04.06.2012 |
| Improved quality of life for patients with chronic wounds | Cosmetics, ointments, chemicals, detergents and medical products all have to undergo skin tolerance tests before they can be launched on the market. | 18.02.2010 |